Pharmaceuticals, Biotechnology and Life Sciences
ProMIS Neurosciences’s lead product candidate for Alzheimer’s disease, PMN310, showed similar ability to cross the blood brain barrier and penetrate…
Novartis’ Xolair has been recommended in new global chronic urticaria guideline, the company noted Tuesday, as add-on therapy for the…
Grupo Biotoscana has launched Basilea’s hospital antibiotic Zevtera (ceftobiprole) in Argentina, Basilea Pharmaceutica said Tuesday.
Hemogenyx Pharmaceuticals has appointed a pioneer in modern cancer research H. Michael Shepard to its Scientific Advisory Board, praising his work…
OptiBiotix Health has bagged a deal with Italian Fine Foods & Pharmaceuticals N.T.M. S.p.A in which it allows Fine Foods…
An investigator-initiated trial at the National Institutes of Health (NIH) in an exploratory Phase I/II clinical trial in primary progressive…
The results of an evaluation of Evgen Pharma’s novel sulforaphane analogues suggest that some of the analogues merit further study as…
Artios Pharma has exercised its option to in-license the first nuclease drug development with Masaryk University in the Czech Republic,…
Abzena has settled with Stanford University about the claims against PacificGMP.
Bristol-Myers Squibb’s Board of Directors has elected José Baselga, M.D., Ph.D., to the Board, effective March 1, 2018. Dr. Baselga will…